Stay current: Follow Cardiac Interventions Today on Twitter @cardiacinterv



LEADLESS II IDE Trial Supports St. Jude Medical’s Nanostim Leadless Pacemaker

September 4, 2015 -- St. Jude Medical, Inc. announced primary results from the LEADLESS II study that confirm the positive benefits of the company’s Nanostim leadless pa…

Coramaze Receives Funding for Development of Mitramaze TMVR System

September 1, 2015 -- Coramaze Technologies GmbH, a German medical device company that is developing the Mitramaze transcatheter mitral valve replacement (TMVR) system, announc…

Five-Year FAME Data Show Sustained Benefit of St. Jude Medical’s PressureWire for FFR-Guided PCI

September 3, 2015 -- St. Jude Medical, Inc. announced that 5-year results from the landmark FAME (Fractional Flow Reserve [FFR] vs Angiography in Multivessel Evaluation) trial…

EXAMINATION Data Show Superiority of EES vs BMS at 5 Years

September 3, 2015 -- The European Society of Cardiology (ESC) announced that findings from the EXAMINATION trial demonstrated the superiority of a second-generation everolimus…

FDA Expands Indication for AstraZeneca’s Brilinta

September 3, 2015 -- AstraZeneca announced that the US Food and Drug Administration (FDA) has approved Brilinta (ticagrelor) tablets at a new 60-mg dose for patients with…

Abbott Vascular Completes Acquisition of Tendyne Holdings

September 2, 2015 -- Abbott Vascular announced that it has completed its acquisition of Tendyne Holdings, Inc., a private medical device company focused on developing minimall…

Abbott Vascular’s Absorb BVS Demonstrates Noninferiority to Xience DES in STEMI Patients

September 1, 2015 -- The European Society of Cardiology announced that Prof. Patrick W. Serruys, MD, presented findings from ABSORB STEMI: the TROFI II trial at the ESC Congre…

physician counsel

Open Payments Update: Will More Data + More Errors = More Physician Peril?

An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review and dispute their records before they go public.

Open Payments Errors Could Put Physicians in a Bad Light

As the Open Payments website becomes more user-friendly, physicians must ensure their disclosures are accurate, or risk misinterpretation.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center




2015 Buyer’s Guide


This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.

Website Design by Sides Media